Schaller Bernhard
Department of Neurology, Freiburgstrasse 10, CH-3010 Berne, Switzerland.
Neuro Endocrinol Lett. 2003 Dec;24(6):425-30.
Clinically non-functioning pituitary adenomas are common tumors of the pituitary gland. No studies have yet documented gender-related differences in the growth and presentation of these tumors and nothing is known about their effects on their subsequent surgical outcome and prognosis.
Twenty-eight patients with non-functioning pituitary adenoma, that met strict inclusion criteria, and that underwent surgical treatment between January 1990 and June 1997, were retrospectively reviewed.
The patient charts, as well as histological (incl. immunohistochemistry) and electron microscopic findings were analyzed. Tumor invasiveness was classified according to the modified Hardy criteria.
Eleven patients were women and seventeen were men; the female-to-male-ratio was 1:1.5. Men were significantly older, both at diagnosis and surgery. Visual field defect and visual acuity deficit were the most common presenting symptoms with similar occurrence both in women and men, whereas blindness predominated in women. Microadenomas and invasive adenomas did not differ significantly in MIB-1 index, but patients less than 35 years old had higher MIB-1 indices (n=4, 1.72+/-1.15), than did patients over 45 years (n=11, 0.63+/-0.42) (p: n.s.). MIB-1 labeling indices were higher in adenomas of female compared to male patients (1.5 +/-1.2 vs. 0.8+/-1.8; p < 0.003). The overall outcome was significantly worse in women than in men.
The biology and the clinical course of clinically non-functioning pituitary adenoma seem to differ in women and men. In men, tumors are smaller and less invasive at surgery, and the outcome is better than in women. The present findings may justify a more aggressive therapeutic approach to clinically non-functioning pituitary adenomas in women than in men, especially to improve the availability of viable pituitary cells at the time of surgery.
临床无功能垂体腺瘤是垂体常见肿瘤。尚无研究记录这些肿瘤在生长和表现方面的性别差异,对其对后续手术结果和预后的影响也一无所知。
回顾性分析了1990年1月至1997年6月间28例符合严格纳入标准并接受手术治疗的无功能垂体腺瘤患者。
分析患者病历以及组织学(包括免疫组化)和电子显微镜检查结果。根据改良的Hardy标准对肿瘤侵袭性进行分类。
11例为女性,17例为男性;男女比例为1:1.5。男性在诊断和手术时年龄显著更大。视野缺损和视力减退是最常见的首发症状,在女性和男性中发生率相似,而失明在女性中更为常见。微腺瘤和侵袭性腺瘤的MIB-1指数无显著差异,但35岁以下患者的MIB-1指数(n = 4,1.72±1.15)高于45岁以上患者(n = 11,0.63±0.42)(p:无统计学意义)。女性患者腺瘤的MIB-1标记指数高于男性患者(1.5±1.2 vs. 0.8±1.8;p < 0.003)。女性的总体预后明显比男性差。
临床无功能垂体腺瘤的生物学特性和临床病程在女性和男性中似乎有所不同。在男性中,肿瘤在手术时较小且侵袭性较低,结果比女性好。目前的发现可能证明对女性临床无功能垂体腺瘤采取比男性更积极的治疗方法是合理的,特别是为了提高手术时存活垂体细胞的可得性。